NL156921B - PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS. - Google Patents

PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS.

Info

Publication number
NL156921B
NL156921B NL6702002A NL6702002A NL156921B NL 156921 B NL156921 B NL 156921B NL 6702002 A NL6702002 A NL 6702002A NL 6702002 A NL6702002 A NL 6702002A NL 156921 B NL156921 B NL 156921B
Authority
NL
Netherlands
Prior art keywords
therapeutic
preparation
chlorethyl
thia
sole
Prior art date
Application number
NL6702002A
Other languages
Dutch (nl)
Other versions
NL6702002A (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NL6702002A publication Critical patent/NL6702002A/xx
Publication of NL156921B publication Critical patent/NL156921B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6702002A 1966-03-08 1967-02-09 PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS. NL156921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE303166A SE319577B (en) 1966-03-08 1966-03-08

Publications (2)

Publication Number Publication Date
NL6702002A NL6702002A (en) 1967-09-11
NL156921B true NL156921B (en) 1978-06-15

Family

ID=20261249

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6702002A NL156921B (en) 1966-03-08 1967-02-09 PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS.

Country Status (6)

Country Link
AT (1) AT266126B (en)
BE (1) BE693977A (en)
DE (1) DE1617286B1 (en)
GB (1) GB1147731A (en)
NL (1) NL156921B (en)
SE (1) SE319577B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (en) * 1978-04-25 1980-09-10 Plc Pharma Licences STABILIZATION PROCEDURE

Also Published As

Publication number Publication date
SE319577B (en) 1970-01-19
DE1617286B1 (en) 1971-05-27
AT266126B (en) 1968-11-11
BE693977A (en) 1967-08-14
NL6702002A (en) 1967-09-11
GB1147731A (en) 1969-04-02

Similar Documents

Publication Publication Date Title
NL190664B (en) SUBSTITUTED BENZHYDRYLPIPERIDINODERATIVES WITH THERAPEUTIC ACTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL149701B (en) PROCEDURE FOR PREPARING AN AGAINST DENTAL CARE AGENT, CONTAINING AS AN ACTIVE INGREDIENT A PHOSPHONIC ACID DERIVATIVE AND FORMED DENTAL CARE.
SE433071B (en) DOSAGE CONTAINER FOR MEDICAL PREPARATIONS
NL7601667A (en) TOPICAL, APPLICABLE PHARMACEUTICAL ANTI-INFLAMMATION PREPARATION AND PROCEDURE FOR PREPARING AND USING IT.
NL149493B (en) PROCESS FOR PREPARING A THERAPEUTIC PREPARATION, FORMED PREPARATION AND PROCESS FOR PREPARING THE ACTIVE COMPOUNDS TO BE APPLIED THEREIN.
NO136793C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY SUBSTITUTED 1,2,4-TRIAZOLE DERIVATIVES.
IT7829207A0 (en) PHARMACEUTICAL PREPARATIONS.
NL168838B (en) PROCESS FOR THE PREPARATION OF COCCIDIOSTATIC AND ANTIBACTERIALLY ACTIVE COMPOUNDS, AND PROCESS FOR THE PREPARATION OF A PREPARATION CONTAINING SUCH A COMPOUND AND OBTAINED PREPARED IN THE USE OF THE INTENDED USE
NL149503B (en) PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION AND A PROCESS FOR THE PREPARATION OF ACTIVE COMPOUNDS TO BE USED THEREIN.
NL151693B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH A BRONCHOSPASMOLYTIC ACTION CONTAINING A DERIVATIVE OF 2-AMINO-1- (3,5-DIHYDROXYPHENYL) ETHANOL AND OBTAINED UNDER APPLICATION OF THIS METHOD OF THE BRONCHOSPASMOLYTIC METHOD OF THE PREPARED METHOD A MEDICINAL 2-AMINO-1- (3,5-DIHYDROXYPHENYL) ETHANOL DERIVATIVE, USED AS AN ACTIVE INGREDIENT IN SUCH MEDICINAL PRODUCT.
NL145853B (en) PROCESS FOR PREPARING 1-ACYLINDOLE DERIVATIVES AND THERAPEUTIC PREPARATIONS CONTAINING AS AN ACTIVE INGREDIENT THE COMPOUNDS THEREFORE OBTAINED.
NL160722C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BY CONTAINING A 6,6-DIFLUORSTEROID IN A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION, AND FORMED PREPARATION AND PROCEDURE FOR PREPARING THE ACTIVE COMPOUNDS.
CA955852A (en) Medicinal preparation for skin diseases
NL156921B (en) PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS.
FR2300550A1 (en) ANTIMICROBIAL DRUG
NL139739B (en) PROCEDURE FOR PREPARING THERAPEUTIC ACTIVE 3,4,5-TRIMETHOXYBENZOIC ACID AMIDES, PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND FORMED PHARMACEUTICAL PREPARATIONS, RECEIVED UNDER APPLICATION.
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
FI51349C (en) Process for the preparation of therapeutically active N-substituted 6,7-benzomorphans.
NL7613452A (en) PHARMACEUTICAL ANTI-FERTILITY PREPARATIONS.
NL162823C (en) PROCESS FOR THE PREPARATION OF DISINFECTIVE PREPARATIONS CONTAINING AN ACTIVE CHLORINE CONTAINING COMPOUND AND A HALOGLYCOLURIL AND OBTAINED PREPARED USES USING THIS PROCESS
FR2755M (en) New therapeutic agents possessing the activity of vitamin b1.
NL7601591A (en) PROCESS FOR PREPARING A THERAPEUTIC PREPARATION AND PROCESS FOR PREPARING THE ACTIVE COMPOUNDS TO BE APPLIED THEREIN.
NL142403B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST LIVER DISEASE, PREPARATION PREPARED USING THIS PROCESS, AND PROCEDURE FOR PREPARING THE ACTIVE COMPONENT OF THE RELATED MEDICINAL PRODUCT.
NL176744C (en) PROCESS FOR THE PREPARATION OF ORTHOSTATIC DYSREGULATION ACTIVE PREPARATIONS.
NL7803977A (en) 2-HYDROXY-2- (5-ISOXAZOLYLMETHYL) -6,7-BENZOMORPHANES, ACID ADDITION SALTS THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: ASTRA

V4 Lapsed because of reaching the maxim lifetime of a patent